All conditions
BPC-157 for other

Post Surgery Recovery

Of the 3 unique stories with a clear outcome, 3 reported it helped (100%).

These are public YouTube testimonials, not clinical evidence. People who tried BPC-157 and got no result rarely post videos — read this as a sample of the positive end of the distribution.

Verdict
100
% positive
3 helped0 partial0 no help
What people tried
peptide protocol peptide therapy
Helped · significantpeptide protocolover 12 weeks
back in 3 months, cleared to return to sports 5 months
Quote at 0:33Tap to play
Helped · significantThin evidencepeptide therapy
peptide therapy allowed me to heal much faster
Quote at 4:08Tap to play
Helped · significantThin evidence
my post-operative patients report healing quicker
What the science says

Related research

All papers →
Animal study· ratmedium
2025

Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats.

This study found that BPC-157 therapy promoted muscle-to-bone reattachment and restored muscle function in rats with detached quadriceps muscles. The therapy showed consistent healing effects at various time points, leading to well-organized bone formation and mature muscle fibers.

Pharmaceutics· Matek D, Matek I et al.
PubMed · PMID 39861766
Animal study· ratmedium
2024

Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpoint.

The study found that BPC-157, a stable gastric pentadecapeptide, rapidly induces vessel recruitment and healing in rats with duodenocolic fistulas, leading to closed defects and resolved leakage. All BPC-157-treated rats showed significant improvement, with no fistula leakage, diarrhea, or weight loss, and reduced adhesion formation and intestinal obstruction.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society· Vukusic D, Zenko Sever A et al.
PubMed · PMID 38583442
Animal study· ratmedium
2023

Pentadecapeptide BPC 157 as Therapy for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization Syndrome in Rats.

This study found that BPC-157 therapy can resolve post-embolization syndrome in rats by activating collateral pathways and counteracting multiorgan failure. The therapy rapidly reversed the symptoms of the syndrome, including prime lung lesions and thromboemboli occluding lung vessels.

Pharmaceuticals (Basel, Switzerland)· Smoday IM, Krezic I et al.
PubMed · PMID 37895979
Animal study· ratmedium
2022

The anti-nociceptive effect of BPC-157 on the incisional pain model in rats.

BPC-157 was found to have a short-term antinociceptive effect in rats with incisional pain, but its effect was limited to a short period after incision and during the initial phase of pain response. The peptide's anti-inflammatory and wound healing effects did not translate to long-term pain relief in this study.

Journal of dental anesthesia and pain medicine· Jung YH, Kim H et al.
PubMed · PMID 35449779